BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Operating cash flow, 2025
- $4.5B
- YoY, 2025
- +32.0%
- 5-year CAGR
- +24.6%
- 10-year CAGR
- +20.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $4.5B | +32.0% |
| 2024 | $3.4B | +37.2% |
| 2023 | $2.5B | +64.0% |
| 2022 | $1.5B | −18.4% |
| 2021 | $1.9B | +24.0% |
| 2020 | $1.5B | −17.9% |
| 2019 | $1.8B | +492.3% |
| 2018 | $310M | −78.3% |
| 2017 | $1.4B | +20.6% |
| 2016 | $1.2B | +71.1% |
| 2015 | $691M | −45.5% |
| 2014 | $1.3B | +14.3% |
| 2013 | $1.1B | −13.3% |
| 2012 | $1.3B | +27.0% |
| 2011 | $1.0B | +210.2% |
| 2010 | $325M | −61.1% |
| 2009 | $835M | −31.3% |
| 2008 | $1.2B | +30.2% |
| 2007 | $934M | — |